A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
A Phase 1, First-in-Human, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Subjects With Advanced Cancers
Sponsor: Janssen Research & Development, LLC
A PHASE1 clinical study on Myelodysplastic Syndromes and Neoplasms, this trial is completed. The trial is conducted by Janssen Research & Development, LLC and has accumulated 67 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
67 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Oct 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE1
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting PHASE1
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1
▶ Show 62 earlier versions
-
Jun 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE1
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE1
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE1
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE1
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE1
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting PHASE1
-
Nov 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE1
-
Oct 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
-
May 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — May 2024 [monthly]
Active Not Recruiting PHASE1
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting PHASE1
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting PHASE1
-
Jan 2024 — Feb 2024 [monthly]
Active Not Recruiting PHASE1
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting PHASE1
-
Nov 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE1
-
Oct 2023 — Nov 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2023 — Oct 2023 [monthly]
Active Not Recruiting PHASE1
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE1
-
Jun 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE1
-
May 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE1
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting PHASE1
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE1
-
Feb 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE1
-
Jan 2023 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE1
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting PHASE1
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting PHASE1
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Apr 2021 — Jun 2021 [monthly]
Recruiting PHASE1
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE1
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE1
-
Jun 2020 — Oct 2020 [monthly]
Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
Jan 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Aug 2018 — Nov 2018 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Research & Development, LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Badalona, Spain , Barcelona, Spain , Boston, United States , Columbus, United States , Düsseldorf, Germany , Frankfurt am Main, Germany , Haifa, Israel , Houston, United States , Jerusalem, Israel , Leipzig, Germany and 8 more locations